ISDA

Deposition Date 2007-12-23

Release Date 2008-12-23

Last Version Date 2024-04-03

Entry Detail

PDB ID:

3BSA

Keywords:

TRANSFERASE

Title:

Crystal Structure of HCV NS5B Polymerase with a Novel Pyridazinone Inhibitor

Biological Source:

Source Organism:

Hepatitis C virus (isolate BK) (Taxon ID: 11105)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.29

R-Value Work:

0.24

R-Value Observed:

0.24

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:RNA-directed RNA polymerase
Mutations:Q544R
Chain IDs:A, B
Chain Length:578
Number of Molecules:2
Biological Source:Hepatitis C virus (isolate BK)

UniProt ID:P26663 Pfam ID:PF00998 EC:3.4.21.98

Ligand Molecules

1PD

Primary Citation

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.

Zhou, Y, Webber, S.E, Murphy, D.E, Li, L.S, Dragovich, P.S, Tran, C.V, Sun, Z, Ruebsam, F, Shah, A.M, Tsan, M, Showalter, R.E, Patel, R, Li, B, Zhao, Q, Han, Q, Hermann, T, Kissinger, C.R, Lebrun, L, Sergeeva, M.V, Kirkovsky, L.Show

Bioorg.Med.Chem.Lett. 18 1413 1418 (2008)

PMID: 18242088 DOI: 10.1016/j.bmcl.2008.01.007

Abstact

5-Hydroxy-3(2H)-pyridazinone derivatives were investigated as inhibitors of genotype 1 HCV NS5B polymerase. The synthesis, structure-activity relationships (SAR), metabolic stability, and structure-based design approach for this new class of compounds are discussed.

Legend

Protein

Chemical

Disease

Primary Citation of related structures